MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $1.18 | Prev. Close $1.16 | Circuit Range N/A |
Day Range $1.15 - $1.20 | Year Range $0.65 - $2.38 | Volume 14,598 |
Average Traded $1.17 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $1.18 | $1.19 | +0.00% |
09-Jun-26 | $1.18 | $1.19 | +2.60% |
08-Jun-26 | $1.21 | $1.16 | +1.32% |
05-Jun-26 | $1.22 | $1.14 | -8.06% |
04-Jun-26 | $1.22 | $1.24 | +3.77% |
03-Jun-26 | $1.21 | $1.20 | -2.85% |
02-Jun-26 | $1.19 | $1.23 | +0.82% |